Griseofulvin Microsize Tablet
Product Images NDC 23155-865

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Griseofulvin Microsize (NDC 23155-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc D/b/a Avet Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Container-label (Griseofulvin Microsize Label 500mg 100)

Container-label (Griseofulvin Microsize Label 500mg 100)
Label for Griseofulvin Tablets, USP (microsize) 500 mg oral tablets by Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc. The label indicates the quantity as 100 tablets and dosage strength as 500 mg. The layout includes directions for use, a barcode, and product identification with NDC 23155-865-01.*
FDA Label Image

Structure (Griseofulvin Tablets Microsize 01)

Structure (Griseofulvin Tablets Microsize 01)
Chemical structure diagram of griseofulvin showing its molecular formula C17H17ClO6 and molecular weight 352.77. The structure includes a chlorinated aromatic ring with methoxy groups and a fused ring system with ketone and methyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.